Atlas Trials

A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease

Clinical trial NCT04590508 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04590508
Sponsor
National University of Natural Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn Disease
Start date
2020-10-01
Primary completion
2024-08-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.